Oral Potassium Chloride Does Not Require Routine Discontinuation Before Surgery
Oral potassium chloride supplementation does not need to be stopped prior to surgery in most cases. Unlike anticoagulants and antiplatelet agents that have specific perioperative management protocols, oral potassium chloride is not addressed in major perioperative medication management guidelines, indicating it is generally safe to continue 1, 2, 3.
Key Clinical Reasoning
The available perioperative management guidelines from the American College of Chest Physicians (2012,2022) and European Heart Rhythm Association (2018) provide extensive recommendations for managing antithrombotic therapy, antiplatelet agents, and anticoagulants around surgery, but notably do not include any recommendations to discontinue oral potassium supplementation 1, 2, 3, 4.
Why Continuation is Appropriate
No bleeding risk: Potassium chloride does not affect coagulation or increase surgical bleeding risk, unlike the medications that do require perioperative interruption 5
Risk of hypokalemia: Abrupt discontinuation could lead to perioperative hypokalemia, which increases risk of cardiac arrhythmias—a potentially life-threatening complication during anesthesia and surgery 6
Metabolic considerations: Surgical stress, NPO status, and fluid shifts can already predispose patients to electrolyte disturbances; maintaining potassium supplementation helps prevent this 5
Important Caveats and Monitoring
Patients Requiring Special Attention
Hold potassium chloride on the morning of surgery if the patient will be NPO, as oral intake is not possible and the medication could cause gastrointestinal irritation without adequate fluid 5.
Consider temporary discontinuation in patients with:
- Severe renal impairment (CrCl <30 mL/min): These patients have impaired potassium excretion and are at higher risk for hyperkalemia, particularly with perioperative hemodynamic changes 7, 8
- Concurrent RAAS inhibitors (ACE inhibitors, ARBs, aldosterone antagonists): The combination increases hyperkalemia risk, especially during perioperative stress 5
- Concurrent NSAIDs: These medications impair renal potassium excretion and increase retention risk 5
Perioperative Management Strategy
Check baseline serum potassium preoperatively in all patients taking potassium supplementation, particularly those with renal impairment or on medications that affect potassium homeostasis 5, 8.
Resume oral potassium chloride postoperatively once the patient can tolerate oral intake and has adequate gastrointestinal function 9.
For patients who cannot take oral medications postoperatively:
- Consider intravenous potassium replacement if serum levels are low
- Monitor potassium levels closely during the transition period
- Be aware that extended-release formulations may not be absorbed properly in patients with altered GI anatomy 10
Common Pitfall to Avoid
Do not confuse oral potassium chloride management with intravenous potassium protocols—the safety concerns about concentrated IV potassium chloride (which should be removed from clinical areas and requires careful dilution) do not apply to oral formulations 11.